4//SEC Filing
Sandrock Alfred 4
Accession 0001104659-22-037149
CIK 0001640266other
Filed
Mar 22, 8:00 PM ET
Accepted
Mar 23, 6:35 PM ET
Size
8.1 KB
Accession
0001104659-22-037149
Insider Transaction Report
Form 4
Sandrock Alfred
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2022-03-22+940,600→ 940,600 totalExercise: $8.55Exp: 2032-03-22→ Common Stock (940,600 underlying) - Award
Common Stock
2022-03-22+100,000→ 100,000 total
Footnotes (2)
- [F1]Consists of shares of common stock issuable under an aggregate of 100,000 restricted stock units ("RSUs") awarded to the Reporting Person pursuant to the Voyager Therapeutics, Inc. 2015 Stock Option and Incentive Plan (the "Plan"). Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is April 1, 2022. The RSU award vests over four years, with 1/4th of the shares of common stock underlying the RSU award vesting on the one-year anniversary of such vesting commencement date and an additional 1/4th of the shares of common stock underlying the RSU award vesting at the end of each successive one-year period thereafter, subject to the Reporting Person's continued service as an employee.
- [F2]This stock option was issued pursuant to the Plan. The vesting commencement date of the option is the grant date, March 22, 2022. The option vests over four years, with 1/4th of the shares of common stock underlying the option vesting upon the one-year anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service as an employee.
Documents
Issuer
Voyager Therapeutics, Inc.
CIK 0001640266
Entity typeother
Related Parties
1- filerCIK 0001577061
Filing Metadata
- Form type
- 4
- Filed
- Mar 22, 8:00 PM ET
- Accepted
- Mar 23, 6:35 PM ET
- Size
- 8.1 KB